Erik Wisniewski
Family · Gardner, MANPI 1992201925
Payments from drug & device makers
Across 120 payments — averaging $21.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$482
- Pfizer$266
- Novo Nordisk$218
- E.r. Squibb & Sons, L.L.C.$182
- Boehringer Ingelheim$168
- AstraZeneca$160
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,591100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,591 in reported general payments places this provider in the 90th percentile of 2,320 family providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 36 | $46,670 |
| JardianceEmpagliflozin | 13 | $22,201 |
| TrulicityDulaglutide | 20 | $19,148 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $16,678 |
| OzempicSemaglutide | 11 | $14,398 |
| JanuviaSitagliptin Phosphate | 15 | $12,372 |
| Omeprazole | 131 | $2,325 |
| Esomeprazole Magnesium | 19 | $2,078 |
| Atorvastatin Calcium | 168 | $1,699 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,256 |
| Ventolin HfaAlbuterol Sulfate | 19 | $1,213 |
| Amlodipine Besylate | 129 | $1,010 |
| Lisinopril | 96 | $979 |
| Sertraline Hcl | 68 | $972 |
| Duloxetine Hcl | 14 | $805 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $266 | $46,67036 claims |
| Boehringer IngelheimJardiance | $168 | $22,20113 claims |
| Lilly USA, LLCTrulicity | $42 | $19,14820 claims |
| GSKTrelegy Ellipta | $146 | $16,67815 claims |
| Novo NordiskOzempic | $218 | $14,39811 claims |
| MerckJanuvia | $51 | $12,37215 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $97268 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,320 family providers in Massachusetts.
Other family in Gardner
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Courtney NixonAmherst$81K
- Elizabeth WalshBrighton$80K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.